Nerves Actively Fuel Early Pancreatic Cancer Growth in Surprising Discovery

Pancreatic cancer, one of the deadliest cancers with poor early detection and treatment outcomes, may be getting unexpected help from an unlikely ally: the nervous system. New research from Cold Spring Harbor Laboratory reveals that nerves actively promote pancreatic cancer development much earlier than scientists previously understood.

Using advanced 3D imaging techniques, researchers discovered that support cells called myCAFs release chemical signals that attract nerve fibers from the sympathetic nervous system. These recruited nerves then release norepinephrine, a stress hormone that binds to the myCAFs and triggers calcium surges within the cells. This calcium spike further activates the myCAFs while simultaneously attracting more nerve fibers, creating a self-sustaining loop that promotes pre-cancerous growth.

The 3D imaging revealed something shocking: instead of scattered nerve fragments seen in traditional 2D images, researchers found thick, interconnected nerve networks woven throughout early lesions. This dense neural architecture appears to create an environment that actively supports tumor development before full cancers even form.

When researchers disrupted this nerve-cancer partnership using neurotoxins to disable the sympathetic nervous system, tumor growth decreased by nearly 50% in experimental models. This dramatic reduction suggests that targeting nerve activity could offer a new therapeutic strategy for preventing pancreatic cancer progression.

The implications are significant because this nerve-myCAF interaction occurs so early in cancer development. Rather than waiting until tumors are established, interventions targeting this neural pathway might prevent pancreatic cancer from taking hold initially. However, translating these laboratory findings into human treatments will require extensive clinical research to ensure safety and effectiveness.